Drugs / Compound Kushen Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02346318 | Nov 2014 → Aug 2017 | lung cancer | Beijing Zheng Ju Medical Technology Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound Kushen Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02346318 ↗ |
| Route | Intravenous | “Compound Kushen Injection 20ml i.v.drip qd, synchronize with radiotherapy, total dosage is 400ml.” NCT02346318 ↗ |